Cefpodoxime

Background: Cefpodoxime is an oral third generation cephalosporin antibiotic with effectiveness against most Gram positive and Gram negative bacteria. Commonly used to treat acute otitis media, pharyngitis, and sinusitis, cefpodoxime proxetil is a prodrug which is absorbed and de-esterified by the intestinal mucosa to Cefpodoxime.

Indication: Indicated for the treatment of patients with mild to moderate infections caused by susceptible strains of the designated microorganisms.

Associated Conditions: Acute Bacterial Exacerbation of Chronic Bronchitis (ABECB), Acute Otitis Media (AOM), Acute Sinusitis, Acute Tracheobronchitis, Acute maxillary sinusitis, Bacterial Infections, Bacterial Pneumonia, Community Acquired Pneumonia (CAP), Lower Respiratory Tract Infection (LRTI), Neisseria Gonorrhoeae Infection, Otitis Media (OM), Pharyngitis, Skin and Soft Tissue Infections (SSTIs), Streptococcal Pharyngitis, Superinfection bacterial, Tonsillitis, Tonsillitis streptococcal, Uncomplicated Urinary Tract Infections, Upper Respiratory Tract Infection, Uncomplicated Lower Respiratory Tract Infection (LRTI), Uncomplicated Upper Respiratory Tract Infection, Uncomplicated Urethritis gonococcal, Uncomplicated skin and subcutaneous tissue bacterial infections

Healthy Patients & Effect of Antibiotics

Not Applicable

Completed

Locations: 🇺🇸
Washington University School of Medicine, Saint Louis, Missouri, United States

Not Applicable

Completed

Locations: 🇺🇸
University of Miami Miller School of Medicine, Miami, Florida, United States
🇺🇸
University of Washington, Seattle, Washington, United States

Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.